bosentan anhydrous has been researched along with Osteoarthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, FC; Dixon, JB; Doan, TN; McKinney, JM; Willett, NJ | 1 |
| Appleton, CT; Beier, F; Usmani, SE | 1 |
2 other study(ies) available for bosentan anhydrous and Osteoarthritis
| Article | Year |
|---|---|
Endothelin-1 inhibits size dependent lymphatic clearance of PEG-based conjugates after intra-articular injection into the rat knee.
Topics: Animals; Biocompatible Materials; Bosentan; Drug Carriers; Drug Liberation; Endothelin-1; Fluorescent Dyes; Injections, Intra-Articular; Kinetics; Knee Joint; Lymphatic Vessels; Male; Optical Imaging; Osteoarthritis; Peptides, Cyclic; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Synovial Fluid; Tissue Distribution | 2019 |
Transforming growth factor-alpha induces endothelin receptor A expression in osteoarthritis.
Topics: Animals; Antihypertensive Agents; Bosentan; Cartilage, Articular; Cells, Cultured; Extracellular Matrix; Male; NF-kappa B; Nitric Oxide Synthase Type II; Organ Culture Techniques; Osteoarthritis; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sulfonamides; Transforming Growth Factor alpha | 2012 |